A series of new drugs that show progress in slowing down early-stage Alzheimer’s symptoms have emerged on the market. One such drug, Lecanemab — approved by the FDA in 2023 — is an infusion therapy that targets amyloid plaques in the brain, which are one of the...
Pregnancy can be a time of worry for all women. For women with epilepsy, managing their disease amid the fluctuating hormones of gestation can greatly compound concerns. A common neurological condition, epilepsy’s impact on women’s reproductive health is complex....
Imagine you’re a working mother raising three children. Your 6-year-old son was born with sickle cell disease, a chronic condition that affects red blood cells and their ability to bring oxygen to the body’s organs. He requires ongoing care and must visit...